Dermapharm Holding SE buy PapaSmurf
Start price
16.10.22
/
50%
€41.22
Target price
16.10.23
-
Performance (%)
-4.17%
End price
06.03.23
€39.50
Summary
This prediction ended on 06.03.23 with a price of €39.50. With a performance of -4.17%, the BUY prediction for Dermapharm Holding SE by PapaSmurf closed slightly in the red. PapaSmurf has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Dermapharm Holding SE | -2.025% | -2.025% | -30.757% |
| iShares Core DAX® | 2.594% | -1.861% | 13.242% |
| iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% |
| iShares Nikkei 225® | 0.687% | -8.704% | 17.510% |
| iShares S&P 500 | 2.209% | -1.988% | 27.632% |